Literature DB >> 19936851

GIST with a twist--upregulation of PDGF-B resulting in metachronous gastrointestinal stromal tumor and dermatofibrosarcoma protuberans.

Colin J McCarthy1, Gavin C O'Brien, Robert J Cummins, Elaine W Kay, Patrick J Broe.   

Abstract

CASE REPORT: A 61-year-old male was referred following an incidental radiological discovery of an intra-abdominal mass. His medical history included excision of a lumbar dermatofibrosarcoma protuberans (DFSP) 5 years previously. A CT scan of the abdomen revealed a mass arising from the greater curvature of the stomach. Upper GI endoscopy was normal. He underwent successful laparoscopic resection of this mass.
MATERIALS AND METHODS: The histology of the abdominal mass revealed a gastrointestinal stromal tumor (GIST) with poor prognostic indicators. Immunohistochemical analysis of the GIST and his previous DFSP was performed.
RESULTS: Immunohistochemistry suggested a link between the GIST and his previous DFSP involving the PDGF signalling system. DISCUSSION: Both GIST and DFSP are extremely rare tumors. A mutation in the platelet-derived growth factor receptor alpha (PDGFR-alpha) has been described in 5-15% of GISTs. It has been shown that DFSP is frequently associated with a translocation between PDGF-B (Chr 22) and COL1A1 (Chr 17), causing continuous activation of PDGFR-beta. Literature review confirms that there are no previously reported cases of both of these tumors occurring in the same patient.
CONCLUSION: We hypothesize that this patient may have a previously undescribed genetic mutation involving the PDGF signalling system, resulting in these two very rare malignancies. Immunohistochemistry studies confirmed the link on this occasion. Improvements in our understanding of the molecular biology of the PDGF system may novel therapeutic targets in the future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19936851     DOI: 10.1007/s11605-009-1088-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  21 in total

Review 1.  Optimizing diagnosis, staging, and management of gastrointestinal stromal tumors.

Authors:  Juan C Gutierrez; Luiz O Pita De Oliveira; Eduardo A Perez; Caio Rocha-Lima; Alan S Livingstone; Leonidas G Koniaris
Journal:  J Am Coll Surg       Date:  2007-07-16       Impact factor: 6.113

2.  Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study.

Authors:  Geir Tryggvason; Hjörtur G Gíslason; Magnús K Magnússon; Jón G Jónasson
Journal:  Int J Cancer       Date:  2005-11-01       Impact factor: 7.396

Review 3.  Management of malignant gastrointestinal stromal tumours.

Authors:  Heikki Joensuu; Christopher Fletcher; Sasa Dimitrijevic; Sandra Silberman; Peter Roberts; George Demetri
Journal:  Lancet Oncol       Date:  2002-11       Impact factor: 41.316

4.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

Authors:  S Hirota; K Isozaki; Y Moriyama; K Hashimoto; T Nishida; S Ishiguro; K Kawano; M Hanada; A Kurata; M Takeda; G Muhammad Tunio; Y Matsuzawa; Y Kanakura; Y Shinomura; Y Kitamura
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

5.  A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors.

Authors:  Lei L Chen; Jonathan C Trent; Elsie F Wu; Gregory N Fuller; Latha Ramdas; Wei Zhang; Austin K Raymond; Victor G Prieto; Caroline O Oyedeji; Kelly K Hunt; Raphael E Pollock; Barry W Feig; Kimberly J Hayes; Haesun Choi; Homer A Macapinlac; Walter Hittelman; Marco A Velasco; Shreyaskumar Patel; Michael A Burgess; Robert S Benjamin; Marsha L Frazier
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

6.  Multiple gastrointestinal stromal and other tumors caused by platelet-derived growth factor receptor alpha gene mutations: a case associated with a germline V561D defect.

Authors:  Barbara Pasini; Ludmila Matyakhina; Thalia Bei; Michael Muchow; Sosipatros Boikos; Barbara Ferrando; J Aidan Carney; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2007-06-12       Impact factor: 5.958

7.  Coexistence of gastrointestinal stromal tumors with other neoplasms.

Authors:  Łukasz Liszka; Ewa Zielińska-Pajak; Jacek Pajak; Dariusz Gołka; Joanna Huszno
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

8.  Gastrointestinal stromal tumors.

Authors:  A Darnell; E Dalmau; C Pericay; E Musulén; J Martín; J Puig; A Malet; E Saigí; M Rey
Journal:  Abdom Imaging       Date:  2006-02-07

9.  PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors.

Authors:  Irene Appolloni; Filippo Calzolari; Evelina Tutucci; Sara Caviglia; Marta Terrile; Giorgio Corte; Paolo Malatesta
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

Review 10.  The role of PDGF in radiation oncology.

Authors:  Minglun Li; Verena Jendrossek; Claus Belka
Journal:  Radiat Oncol       Date:  2007-01-11       Impact factor: 3.481

View more
  2 in total

1.  The Relationship of Clinicopathological Findings and PDGFR-β Expression With Tumor Recurrence in Gastrointestinal Stromal Tumors.

Authors:  Esin Kaymaz; İlhan Taşdöven; Figen Barut
Journal:  Turk J Gastroenterol       Date:  2021-12       Impact factor: 1.555

2.  Frequency, localization, and types of gastrointestinal stromal tumor-associated neoplasia.

Authors:  Johanna Waidhauser; Anne Bornemann; Martin Trepel; Bruno Märkl
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.